BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Khan FZ, Perumpail RB, Wong RJ, Ahmed A. Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma. World J Hepatol 2015; 7(18): 2155-2161 [PMID: 26328027 DOI: 10.4254/wjh.v7.i18.2155]
URL: https://www.wjgnet.com/1948-5182/full/v7/i18/2155.htm
Number Citing Articles
1
John D. Groopman. Hepatocellular Carcinoma2016; : 25 doi: 10.1007/978-3-319-34214-6_2
2
Shangfu Li, Dan Gao, Yuyang Jiang. Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular CarcinomaMetabolites 2019; 9(2): 36 doi: 10.3390/metabo9020036
3
Minoru Tomizawa, Fuminobu Shinozaki, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Naoki Ishige. 2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cellsOncology Letters 2017; 13(2): 800 doi: 10.3892/ol.2016.5510
4
Laurence Britton, Lesley-Anne Jaskowski, Kim Bridle, Eriza Secondes, Daniel Wallace, Nishreen Santrampurwala, Janske Reiling, Gregory Miller, Salvatore Mangiafico, Sofianos Andrikopoulos, V. Nathan Subramaniam, Darrell Crawford. Ferroportin Expression in Adipocytes Does Not Contribute to Iron Homeostasis or Metabolic Responses to a High Calorie DietCellular and Molecular Gastroenterology and Hepatology 2018; 5(3): 319 doi: 10.1016/j.jcmgh.2018.01.005
5
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular CarcinomaAmerican Society of Clinical Oncology Educational Book 2018; (38): 262 doi: 10.1200/EDBK_200939
6
John D. Groopman. Liver Cancer in the Middle East2021; : 13 doi: 10.1007/978-3-030-78737-0_2
7
Subrat K. Acharya, Sawan Bopanna. Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?Journal of Clinical and Experimental Hepatology 2020; 10(5): 518 doi: 10.1016/j.jceh.2020.04.004
8
Jonathan G. Stine, Brian J. Wentworth, Alex Zimmet, Mary E. Rinella, Rohit Loomba, Stephen H. Caldwell, Curtis K. Argo. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseasesAlimentary Pharmacology & Therapeutics 2018; 48(7): 696 doi: 10.1111/apt.14937
9
Brian I. Carr, Gianluigi Giannelli, Vito Guerra, Edoardo G Giannini, Fabio Farinati, Gian Ludovico Rapaccini, Maria Di Marco, Marco Zoli, Eugenio Caturelli, Alberto Masotto, Roberto Virdone, Rodolfo Sacco, Franco Trevisani. Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patientsThe International Journal of Biological Markers 2018; 33(4): 423 doi: 10.1177/1724600818776838
10
Mayuko Ichimura, Miki Masuzumi, Miku Kawase, Mika Sakaki, Shizuka Tamaru, Yasuo Nagata, Kazunari Tanaka, Kazuhito Suruga, Koichi Tsuneyama, Satoru Matsuda, Katsuhisa Omagari. A diet-induced Sprague–Dawley rat model of nonalcoholic steatohepatitis-related cirrhosisThe Journal of Nutritional Biochemistry 2017; 40: 62 doi: 10.1016/j.jnutbio.2016.10.007
11
Vlad Ratziu, Arun Sanyal, Stephen A. Harrison, Vincent Wai‐Sun Wong, Sven Francque, Zachary Goodman, Guruprasad P. Aithal, Kris V. Kowdley, Star Seyedkazemi, Laurent Fischer, Rohit Loomba, Manal F. Abdelmalek, Frank Tacke. Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR StudyHepatology 2020; 72(3): 892 doi: 10.1002/hep.31108
12
William P. Esler, Kendra K. Bence. Metabolic Targets in Nonalcoholic Fatty Liver DiseaseCellular and Molecular Gastroenterology and Hepatology 2019; 8(2): 247 doi: 10.1016/j.jcmgh.2019.04.007
13
Omar Massoud, Michael Charlton. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular CarcinomaClinics in Liver Disease 2018; 22(1): 201 doi: 10.1016/j.cld.2017.08.014
14
Yvonne Huber, Christian Labenz, Maurice Michel, Marcus-A. Wörns, Peter R. Galle, Karel Kostev, Jörn M. Schattenberg. Tumor Incidence in Patients with Non-Alcoholic Fatty Liver DiseaseDeutsches Aerzteblatt Online 2020;  doi: 10.3238/arztebl.2020.0719
15
Yvonne P. Dragan. Hepatocellular Carcinoma2016; : 65 doi: 10.1007/978-3-319-34214-6_4
16
David H. Van Thiel, Salamah Mohammad Alwahsh, Giuliano Ramadori. Hepatocellular Carcinoma2016; : 287 doi: 10.1007/978-3-319-34214-6_19
17
Chiara Lopane, Pasquale Agosti, Isabella Gigante, Carlo Sabbà, Antonio Mazzocca. Implications of the lysophosphatidic acid signaling axis in liver cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017; 1868(1): 277 doi: 10.1016/j.bbcan.2017.06.002
18
Ans Jacobs, Anne‐Sophie Warda, Jef Verbeek, David Cassiman, Pieter Spincemaille. An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to PresentCurrent Protocols in Mouse Biology 2016; 6(2): 185 doi: 10.1002/cpmo.3
19
Salvatore Lorenzo Renne, Samantha Sarcognato, Diana Sacchi, Maria Guido, Massimo Roncalli, Luigi Terracciano, Luca Di Tommaso. Hepatocellular carcinoma: a clinical and pathological overviewPathologica 2021; 113(3): 203 doi: 10.32074/1591-951X-295
20
Xu Li, Xiaocong Wang, Pujun Gao. Diabetes Mellitus and Risk of Hepatocellular CarcinomaBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5202684
21
Tony S. Brar, Eric Hilgenfeldt, Consuelo Soldevila-Pico. Precision Molecular Pathology of Liver CancerMolecular Pathology Library 2018; : 1 doi: 10.1007/978-3-319-68082-8_1
22
JIN-YAN ZHANG, MING-ZHE WENG, FANG-BIN SONG, YONG-GANG XU, QI LIU, JUN-YI WU, JUN QIN, TAO JIN, JUN-MING XU. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signalingInternational Journal of Oncology 2016; 48(4): 1590 doi: 10.3892/ijo.2016.3385
23
George Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya K Satapathy. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for managementWorld Journal of Hepatology 2017; 9(11): 533-543 doi: 10.4254/wjh.v9.i11.533
24
Tahereh Setayesh, Steven D. Colquhoun, Yu-Jui Yvonne Wan. Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinomaLiver Research 2020; 4(4): 173 doi: 10.1016/j.livres.2020.11.001
25
Özlem Akdoğan, Ayşegül Atak Yücel, Zeynep Gök Sargin, Cemile Sönmez, Güldal Esendağli Yilmaz, Seren Özenirler. Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis MarkerJournal of Clinical and Experimental Hepatology 2019; 9(1): 29 doi: 10.1016/j.jceh.2018.02.001
26
Paola Dongiovanni, Marica Meroni, Salvatore Petta, Miriam Longo, Anna Alisi, Giorgio Soardo, Luca Valenti, Luca Miele, Stefania Grimaudo, Grazia Pennisi, Grieco Antonio, Dario Consonni, Silvia Fargion, Anna Ludovica Fracanzani. Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLDBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(10): 158765 doi: 10.1016/j.bbalip.2020.158765
27
Priyankar Dey, Joshua B. Kim, Chureeporn Chitchumroonchokchai, Jinhui Li, Geoffrey Y. Sasaki, Bryan D. Olmstead, Katie L. Stock, Jennifer M. Thomas-Ahner, Steven K. Clinton, Richard S. Bruno. Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitisFood & Function 2019; 10(10): 6351 doi: 10.1039/C9FO01199D
28
Reham F. Amin, Amal S. El Bendary, Sherif E. Ezzat, Waleed S. Mohamed. Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patientsDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(3): 2226 doi: 10.1016/j.dsx.2019.05.030
29
Laleh Sharifi. Nutrition and Immunity2019; : 283 doi: 10.1007/978-3-030-16073-9_13
30
J.D. Groopman. Comprehensive Toxicology2018; : 188 doi: 10.1016/B978-0-12-801238-3.64104-1
31
Ge Chenxu, Xu Minxuan, Qin Yuting, Gu Tingting, Feng Jing, Lv Jinxiao, Wang Sujun, Ma Yongjie, Lou Deshuai, Li Qiang, Hu Linfeng, Nie Xuyuan, Wang Mingxing, Huang Ping, Tan Jun. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stressFree Radical Biology and Medicine 2019; 134: 23 doi: 10.1016/j.freeradbiomed.2018.12.034
32
Encheng Yang, Xiao Li, Ningyi Jin. The chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatmentCancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0351-0
33
Kelly E Mercer, Casey F Pulliam, Kim B. Pedersen, Leah Hennings, Martin JJ Ronis. Soy protein isolate inhibits hepatic tumor promotion in mice fed a high-fat liquid dietExperimental Biology and Medicine 2017; 242(6): 635 doi: 10.1177/1535370216685436
34
Laurence J Britton, V Nathan Subramaniam, Darrell HG Crawford. Iron and non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2016; 22(36): 8112-8122 doi: 10.3748/wjg.v22.i36.8112
35
Neeta B. Amin, Santos Carvajal-Gonzalez, Julie Purkal, Tong Zhu, Collin Crowley, Sylvie Perez, Kristin Chidsey, Albert M. Kim, Bryan Goodwin. Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitisScience Translational Medicine 2019; 11(520): eaav9701 doi: 10.1126/scitranslmed.aav9701
36
Qing Ye, Bao-Xin Qian, Wei-Li Yin, Feng-Mei Wang, Tao Han, Pavel Strnad. Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 ControlsPLOS ONE 2016; 11(9): e0163423 doi: 10.1371/journal.pone.0163423
37
Minqian Shen, Haifei Shi, Antimo Migliaccio. Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 CellsPLOS ONE 2016; 11(3): e0151455 doi: 10.1371/journal.pone.0151455
38
Chang-Nim Im. Past, present, and emerging roles of mitochondrial heat shock protein TRAP1 in the metabolism and regulation of cancer stem cellsCell Stress and Chaperones 2016; 21(4): 553 doi: 10.1007/s12192-016-0687-3
39
John D Groopman. Environmental health in the biology century: Transitions from population to personalized preventionExperimental Biology and Medicine 2019; 244(9): 728 doi: 10.1177/1535370219837903